News

June 8, 2016

Review Study Finds Strong Link Between Smoking and Development of Psoriasis

News

The association between tobacco smoking and the onset of psoriasis was recently reviewed in a study, “Psoriasis and smoking: links and risks,” published in Psoriasis: Targets and Therapy. Tobacco smoke ... Read more

June 7, 2016

In Psoriasis and Psoriatic Arthritis Patients, Biologics Therapy Seems to Help Depression and Insomnia

News

Researchers at several Chinese medical and research institutions investigated the effects of biologics therapy — namely tumor necrosis factor inhibitors — on the psychological symptoms and well-being of psoriasis patients, and found ... Read more

June 6, 2016June 6, 2016

Potential New Avenue for Development of Psoriasis Treatment as Researchers Discover How ADAM17 Works

News

A new study out of Germany could advance the understanding of how an overactive immune system leads to the excess of inflammation that occurs in many different diseases, including psoriasis. ... Read more

May 27, 2016May 27, 2016

Identifying Key Contributors to Psoriasis Disease Progression, Possibly Leading to Future Treatment Targets

News

Psoriasis is a chronic autoimmune disease characterized by excess inflammation of skin cells called keratinocytes, resulting in itching, burning, and stinging sensations of the skin. Excess inflammation of keratinocytes is mediated through the ... Read more

May 25, 2016May 25, 2016

Psoriasis Biosimilar SB2 by Samsung Bioepis Accepted for FDA Review

News

Samsung Bioepis recently announced in a press release that the U.S. FDA has accepted the company’s Biologics License Application for its biosimilar drug candidate SB2, which references Remicade (infliximab). The drug is indicated ... Read more

May 23, 2016May 23, 2016

Independent Psoriasis Registry to Track Safety of Recently Approved Treatment Taltz (Ixekizumab)

News

The Portland, Oregon-based Corrona Psoriasis Registry announced it has been selected to track drug safety reporting for ixekizumab, a new biologic medication developed by global pharma Eli Lilly of Indianapolis, which markets ... Read more

May 20, 2016May 20, 2016

Challenges of Living with Psoriasis Dramatized in New Film ‘Millefeuille’

News

A culmination of its extended research into psoriasis and psoriatic arthritis, global pharmaceutical company Celgene is launching a fictional dramatization highlighting the unhappiness and frustration experienced by patients struggling with ... Read more

May 19, 2016May 19, 2016

Study in Danish Twins ‘Strongly’ Links Psoriasis to Obesity and Type 2 Diabetes

News

A study using data collected from Danish twins found that psoriasis is associated with type 2 diabetes, body mass index and obesity. The findings also indicate a potential common genetic ... Read more

May 17, 2016May 17, 2016

Psoriasis Vulgaris a Distinct Disease from Two Separate but Similar Conditions, According to Genetic Analysis

News

A study published in the latest edition of the journal PLOS one used gene expression microarray analysis of genetic data to compare the genetic similarities and differences between palmoplantar pustulosis psoriasis, ... Read more

May 16, 2016May 16, 2016

Researchers Publish Review of Psoriasis Treatment Methotrexate

News

Scottish researchers published a new meta-analysis of the medical literature evaluating whether the medication methotrexate is safe and effective for treating psoriasis. The research report, “Safety and Efficacy of Methotrexate ... Read more